Frequently Asked Questions
The market is segmented based on , By Type (DNA-Based Aptamers, RNA-Based Aptamers and XNA-Based Aptamers), Application (Diagnostics, Therapeutics Development, Research and Development and Other Applications), Technology (SELEX, and Other Technologies), End Users (Academic and Government Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations and Other End Users) – Industry Trends and Forecast to 2031.
.
The Global Aptamers Market size was valued at USD 194.66 USD Million in 2023.
The Global Aptamers Market is projected to grow at a CAGR of 20.16% during the forecast period of 2024 to 2031.
The major players operating in the market include Vivonics Inc. (U.S.), TriLink BioTechnologies (U.S.), SomaLogic Operating Co., Inc. (U.S.), NeoVentures Biotechnology Inc. (Canada), Base Pair Biotechnologies (U.S.), AptaTargets SL (Spain), Aptamer Group (U.K.), Aptamer Sciences, Inc. (U.S.), Aptagen, LLC (U.S.), KANEKA CORPORATION (Japan), LUMITOS AG (Germany), AMS Biotechnology (Europe) Limited (U.K.), Creative Biogene (U.S.), ATDBio Ltd (U.K.), NOVAPTECH (U.S.), and 2bind GmbH (Germany).
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
